Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation
Open Access
- 1 July 2016
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 37, 1-9
Abstract
No abstract availableKeywords
Funding Information
- Dutch Kidney Foundation consortium (CP09.04)
- Alexander von Humboldt (AvH) Foundation
- AvH and TTS fellowships
This publication has 49 references indexed in Scilit:
- Impact of Commonly Used Transplant Immunosuppressive Drugs on Human NK Cell Function Is Dependent upon Stimulation ConditionPLOS ONE, 2013
- Autologous Mesenchymal Stromal Cells and Kidney TransplantationClinical Journal of the American Society of Nephrology, 2011
- Renal Transplant Immunosuppression Impairs Natural Killer Cell Function In Vitro and In VivoPLOS ONE, 2010
- Towards a Genetic Definition of Cancer-Associated InflammationThe American Journal of Pathology, 2010
- CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2ALeukemia, 2009
- Reciprocal Interactions Between Human Mesenchymal Stem Cells and γδ T Cells Or Invariant Natural Killer T CellsStem Cells, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem CellsStem Cells, 2005
- In vivo evidence for a dependence on interleukin 15 for survival of natural killer cellsBlood, 2002
- Molecular mechanisms of anti‐inflammatory action of glucocorticoidsBioEssays, 1996